• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

Meta-analyses of the effects of Dpp-4 inhibitors, SGLT2 inhibitors and GLP1 receptor analogues on cardiovascular death, myocardial infarction, stroke and hospitalization for heart failure
To assess the effects DPP- 4i; SGLT2-i& GLP1-RA on CV death, MI, stroke and hHF . This is probably the first meta-analysis to assess the effects of these drugs on MI and stroke in totality, including non-fatal& fatal MI and stroke.
Source: Diabetes Research and Clinical Practice - February 19, 2019 Category: Endocrinology Authors: Binayak Sinha, Samit Ghosal Source Type: research

Effect of Ramadan fasting on incidence of Cerebrovascular stroke in Egyptian patients with Type 2 Diabetes Mellitus
Diabetes is an independent risk factor for stroke disease. Fasting during Ramadan, Muslims must abstain from eating, drinking, taking oral medications, and smoking from the exact time of dawn until time of sunset; in this study we investigated if there is impact of Ramadan Fasting on incidence of Cerebrovascular stroke among Patients with Type 2 Diabetes Mellitus. This cross sectional study was conducted in medical ICU of Zagazig University Hospitals, in months of Sha ’ban, Ramadan and Shawwal, in 1436; total numbers of 220 patients diagnosed as cerebrovascular stroke were enrolled in.
Source: Diabetes Research and Clinical Practice - March 18, 2019 Category: Endocrinology Authors: Mohamed H. Asy, Mohamed Awd, Arafa M. Elshabrawy, Mahmoud Gharieb Source Type: research

Stroke in the patient with diabetes (Part 2) -Prevention and the effects of glucose lowering therapies
There is a higher incidence of stroke in both the type 2 diabetic and the non-diabetic insulin resistant patient which is accompanied by higher morbidity and mortality. Stroke primary prevention can be achieved by controlling atrial fibrillation and hypertension, and the utilization of statins and anticoagulant therapies. Utilizing pioglitazone and GLP-1 receptor agonists reduce the risk of stroke while the utilization of metformin, α-glucosidase inhibitors, DPP-4 and SGLT-2 inhibitors have no effect.
Source: Diabetes Research and Clinical Practice - May 11, 2020 Category: Endocrinology Authors: David S.H. Bell, Edison Goncalves Tags: Review Source Type: research

Stroke in the patient with diabetes (Part 1) - Epidemiology, etiology, therapy and prognosis
There is a higher incidence of stroke in both the type 2 diabetic and the non-diabetic insulin resistant patient which is accompanied by higher morbidity and mortality. The increase in the frequency of stroke is due to an increase in cerebral infarction, mainly lacunar infarcts, with the incidence of cerebral hemorrhage being less frequent. The major risk factors for stroke in the type 2 diabetic patient are age, hypertension, the number of features of the Metabolic Syndrome, the presence of diabetic nephropathy in both the type 1 and type 2 patient, the presence of peripheral and coronary artery disease and especially the...
Source: Diabetes Research and Clinical Practice - May 18, 2020 Category: Endocrinology Authors: David S.H. Bell, Edison Goncalves Tags: Review Source Type: research

Stroke in the patient with diabetes (part 1) – Epidemiology, etiology, therapy and prognosis
There is a higher incidence of stroke in both the type 2 diabetic and the non-diabetic insulin resistant patient which is accompanied by higher morbidity and mortality. The increase in the frequency of stroke is due to an increase in cerebral infarction, mainly lacunar infarcts, with the incidence of cerebral hemorrhage being less frequent. The major risk factors for stroke in the type 2 diabetic patient are age, hypertension, the number of features of the Metabolic Syndrome, the presence of diabetic nephropathy in both the type 1 and type 2 patient, the presence of peripheral and coronary artery disease and especially the...
Source: Diabetes Research and Clinical Practice - May 18, 2020 Category: Endocrinology Authors: David S.H. Bell, Edison Goncalves Tags: Review Source Type: research

Stroke in the patient with diabetes (Part 2) – Prevention and the effects of glucose lowering therapies
There is a higher incidence of stroke in both the type 2 diabetic and the non-diabetic insulin resistant patient which is accompanied by higher morbidity and mortality. Stroke primary prevention can be achieved by controlling atrial fibrillation and hypertension, and the utilization of statins and anticoagulant therapies. Utilizing pioglitazone and GLP-1 receptor agonists reduce the risk of stroke while the utilization of metformin, α-glucosidase inhibitors, DPP-4 and SGLT-2 inhibitors have no effect.
Source: Diabetes Research and Clinical Practice - May 11, 2020 Category: Endocrinology Authors: David S.H. Bell, Edison Goncalves Tags: Review Source Type: research

Admission hyperglycemia, stroke subtypes, outcomes in acute ischemic stroke
Whether admission hyperglycemia is differentially associated with early vascular outcomes in acute ischemic stroke(AIS) depending on stroke subtype has been incompletely delineated.
Source: Diabetes Research and Clinical Practice - January 11, 2023 Category: Endocrinology Authors: Joon-Tae Kim, Ji Sung Lee, Beom Joon Kim, Jihoon Kang, Keon-Joo Lee, Jong-Moo Park, Kyusik Kang, Soo Joo Lee, Jae Guk Kim, Jae-Kwan Cha, Dae-Hyun Kim, Tai Hwan Park, Kyung Bok Lee, Jun Lee, Keun-Sik Hong, Yong-Jin Cho, Hong-Kyun Park, Byung-Chul Lee, Kyun Source Type: research

Establishment and validation of a prediction model for ischemic stroke risks in patients with type 2 diabetes
Diabetes is a formidable global health threat because of its high prevalence and numerous complications. Furthermore, diabetes is a leading cause of mortality and microvascular and macrovascular diseases, including coronary diseases, cerebrovascular diseases, and peripheral vascular diseases. A recent study reports that risk of stroke in patients with type 2 diabetes is two to five times higher than the general population[1]. The World Health Organization MONICA project reported that stroke incidence is higher among ethnic Chinese population than among Western population [2].
Source: Diabetes Research and Clinical Practice - February 17, 2018 Category: Endocrinology Authors: Tsai-Chung Li, Hsiang-Chi Wang, Chia-Ing Li, Chiu-Shong Liu, Wen-Yuan Lin, Chih-Hsueh Lin, Sing-Yu Yang, Cheng-Chieh Lin Source Type: research

A model to predict risk of stroke in middle-aged adults with type 2 diabetes generated from a nationwide population-based cohort study in Korea
This study aimed to develop a model to predict the risk of stroke in middle-aged patients with type 2 DM.
Source: Diabetes Research and Clinical Practice - April 21, 2020 Category: Endocrinology Authors: Mee Kyoung Kim, Kyungdo Han, Jae-Hyoung Cho, Hyuk-Sang Kwon, Kun-Ho Yoon, Seung-Hwan Lee Source Type: research

Increased Neutrophil Elastase and Proteinase 3 Are Closely Associated with Occurrence and Severity of Stroke and Acute Myocardial Infarction in Patients with Type 2 Diabetes Mellitus
This study aimed to investigate the relationship and predictive ability of NE and PR3 in the development of stroke and AMI in patients with T2DM, and to explore the pattern of NE and PR3 in atherosclerotic plaques.
Source: Diabetes Research and Clinical Practice - March 23, 2022 Category: Endocrinology Authors: Lihong Wang, Jie Pan, Yifan Sun, Shuhang Zong, Rui Zhang, Yue Li, Zhiyan Yu, Jun Liu, Shufei Zang Source Type: research

The potential long-term neurological improvement of early hyperbaric oxygen therapy on hemorrhagic stroke in the diabetics
Compared with ischemic stroke, intracerebral hemorrhage (ICH) is a kind of acute cerebral disorder with relatively worse neurobehavioral deterioration. The whole pathological progress of ICH is hasty and the onset of signs or symptoms commonly occurs within tens of minutes. It is believed that the onset of ICH is induced by potential complications of hypertension or diabetes [1]. Since the worldwide incidences of cardiovascular diseases (especially hypertension and diabetes) increase rapidly in recent years, the potential risk of ICH is also a rigorous challenge in these days [2].
Source: Diabetes Research and Clinical Practice - February 3, 2018 Category: Endocrinology Authors: Qian Xu, Shuang-bo Fan, Yu-lin Wan, Xian-lan Liu, Liang Wang Source Type: research

Age-specific rate of undiagnosed diabetes and prediabetes in acute stroke
We investigated age-specific rates of undiagnosed diabetes and prediabetes among patients with acute stroke.
Source: Diabetes Research and Clinical Practice - December 8, 2019 Category: Endocrinology Authors: Paola Forti, Fabiola Maioli, Giorgia Arnone, Valeria Nativio, Marco Zoli, Maura Coveri, Giuseppe Di Pasquale, Gaetano Procaccianti Source Type: research

Incidence of stroke and its association with glycemic control and lifestyle in Japanese patients with type 2 diabetes mellitus: the Fukuoka Diabetes Registry
We prospectively investigated the incidence of stroke and its subtypes, risk factors and prognosis in Japanese patients with type 2 diabetes.
Source: Diabetes Research and Clinical Practice - October 20, 2020 Category: Endocrinology Authors: Masanori Iwase, Yuji Komorita, Toshiaki Ohkuma, Hiroki Fujii, Hitoshi Ide, Masahito Yoshinari, Yutaro Oku, Taiki Higashi, Udai Nakamura, Takanari Kitazono Source Type: research

Pages: 1  2  3  4  5